Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients.

Trial Profile

Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients.

Completed
Phase of Trial: Phase III

Latest Information Update: 01 May 2013

At a glance

  • Drugs Pioglitazone (Primary) ; Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms COMPASS
  • Most Recent Events

    • 03 Sep 2012 Planned number of patients changed from 120 to 130 as reported by University Hospital Medical Information Network - Japan.
    • 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
    • 21 Dec 2011 Additional lead trial centre identified as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top